SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $909,367 | -32.4% | 19,340 | -53.6% | 0.03% | -30.6% |
| Q2 2022 | $1,346,000 | +377.3% | 41,684 | +388.7% | 0.05% | +345.5% |
| Q1 2022 | $282,000 | -72.6% | 8,530 | -52.9% | 0.01% | -83.3% |
| Q2 2021 | $1,028,000 | +391.9% | 18,094 | +259.9% | 0.07% | +500.0% |
| Q2 2020 | $209,000 | -36.5% | 5,028 | -56.1% | 0.01% | -54.2% |
| Q1 2020 | $329,000 | -68.2% | 11,452 | -20.1% | 0.02% | -46.7% |
| Q4 2019 | $1,034,000 | +370.0% | 14,326 | +1092.8% | 0.04% | +275.0% |
| Q2 2019 | $220,000 | -32.9% | 1,201 | -88.3% | 0.01% | -53.8% |
| Q1 2016 | $328,000 | +54.0% | 10,234 | +103.4% | 0.03% | +44.4% |
| Q3 2015 | $213,000 | – | 5,031 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |